TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36456912

Group type: EXPERIMENTAL
Intervention: Different cover letter information and incentives
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Reading the cover letter carefully
Number of subjects: 960
Study: 34037294

Group type: EXPERIMENTAL
Intervention: Considering COVID‐19 vaccination
Number of subjects: 1557

Group type: EXPERIMENTAL
Intervention: Undecided about COVID‐19 vaccination
Number of subjects: 1557

Group type: EXPERIMENTAL
Intervention: Not wanting COVID‐19 vaccination
Number of subjects: 1557

Group type: EXPERIMENTAL
Intervention: Predictive factors for willingness to vaccination
Number of subjects: 1557

Group type: EXPERIMENTAL
Intervention: Preference for a given vaccine
Number of subjects: 1557
Study: 33736600

Group type: EXPERIMENTAL
Intervention: Persian version of the Respectful Maternity Care (RMC) questionnaire
Number of subjects: 150
Study: 32089848

Group type: EXPERIMENTAL
Intervention: Educational intervention in social insurance medicine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study: 32139090

Group type: EXPERIMENTAL
Intervention: BSC (halamine antimicrobial curtains)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BSC-pre (halamine antimicrobial curtains sprayed twice weekly with sodium hypochlorite)
Number of subjects: 0

Group type: COMPARATOR
Intervention: SC (standard curtain)
Number of subjects: 0
Study: 34607172

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 44
Study: 34668112

Group type: EXPERIMENTAL
Intervention: Specialty Mental Health Probation (SMHP) officers
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Specialty Mental Health Probation (SMHP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard probation
Number of subjects: 100
Study: 33468148

Group type: EXPERIMENTAL
Intervention: Foot massage treatment (10-min daily for four weeks using sweet almond oil)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Foot massage treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no foot massage treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 35666314

Group type: EXPERIMENTAL
Intervention: OPERA® dietary supplement (α‐Lipoic acid, Boswellia serrata, Methylsulfonylmethane, and Bromelain) taken once a day for six months (T0 to T3)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: OPERA® dietary supplement
Number of subjects: 53
Study: 34738701

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 172

Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 172
Study: 33684596

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D supplementation
Number of subjects: 1788

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1788
Study: 36266167

Group type: EXPERIMENTAL
Intervention: Submental flap reconstruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Obturator rehabilitation
Number of subjects: 0
Study: 32329437

Group type: EXPERIMENTAL
Intervention: Tailored Approach to Sleep Health Education (TASHE)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Standard sleep information via the National Sleep Foundation website (Control)
Number of subjects: 194
Study: 37323710

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Abdominal training
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control (standard in-hospital treatment)
Number of subjects: 81
Study: 35033635

Group type: EXPERIMENTAL
Intervention: Vortioxetine 10 mg
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Vortioxetine 20 mg
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg
Number of subjects: 616

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 616
Study: 33445146

Group type: COMPARATOR
Intervention: CT (Concurrent Training)
Number of subjects: 45

Group type: COMPARATOR
Intervention: CT + EL (Concurrent Training + Eurycoma longifolia)
Number of subjects: 45
Study: 32063157

Group type: EXPERIMENTAL
Intervention: Nebulised normal saline administered hourly
Number of subjects: 199

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 199
Study: 34323341

Group type: EXPERIMENTAL
Intervention: Modified WHO cholera solution
Number of subjects: 27

Group type: COMPARATOR
Intervention: Glucodrate® (Vitaflo)
Number of subjects: 27
Study: 34121047

Group type: EXPERIMENTAL
Intervention: Carbohydrate restriction at breakfast
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Carbohydrate restriction at dinner
Number of subjects: 43
Study: 35723003

Group type: EXPERIMENTAL
Intervention: Bright Light (1300 lux)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Dim Light (6 lux)
Number of subjects: 8
Study: 33261635

Group type: EXPERIMENTAL
Intervention: HEAVY (progressive heavy shoulder strengthening programme)
Number of subjects: 100

Group type: COMPARATOR
Intervention: LIGHT (low-load training and general advice)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: HEAVY
Number of subjects: 100

Group type: COMPARATOR
Intervention: LIGHT
Number of subjects: 100
Study: 33559186

Group type: EXPERIMENTAL
Intervention: Thiamidol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle treatment
Number of subjects: 0
Study: 32423454

Group type: EXPERIMENTAL
Intervention: Neck-specific strengthening exercise
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham ultrasound
Number of subjects: 42
Study: 36163766

Group type: EXPERIMENTAL
Intervention: Tamibarotene/venetoclax/azacitidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Venetoclax/azacitidine
Number of subjects: 0
Study: 34024677

Group type: EXPERIMENTAL
Intervention: Innovative loading device for weightbearing CT imaging
Number of subjects: 10
Study: 32418164

Group type: EXPERIMENTAL
Intervention: Personalized cognitive counseling (PCC)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control
Number of subjects: 153
Study: 616695385

Group type: EXPERIMENTAL
Intervention: Participation in an academic course and a social networking and support website for 24 months
Number of subjects: 0
Study: 34955173

Group type: EXPERIMENTAL
Intervention: Vaginal Stretching with Photobiomodulation Therapy (PBMT)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Vaginal Stretching with Sham PBMT
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Vaginal Stretching with PBMT
Number of subjects: 103
Study: 34059568

Group type: EXPERIMENTAL
Intervention: Plyometric training (PMT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (regular PE classes)
Number of subjects: 100
Study: 32620210

Group type: EXPERIMENTAL
Intervention: GC-avelumab (gemcitabine 1000 mg/m2 on days 1 and 8, Cisplatin 70 mg/m2 on day 1, plus Avelumab 10 mg/kg every 3 weeks)
Number of subjects: 90

Group type: COMPARATOR
Intervention: GC (gemcitabine 1000 mg/m2 on days 1 and 8, Cisplatin 70 mg/m2 on day 1)
Number of subjects: 90
Study: 36137654

Group type: EXPERIMENTAL
Intervention: Surgical management (preferred by neurosurgeons)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (preferred by interventional neuroradiologists)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Agreement among specialists
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Trial participation offer
Number of subjects: 60
Study: 32132141

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 2158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2158
Study: 616639227

Group type: EXPERIMENTAL
Intervention: Oxford House (OH) recovery homes
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual aftercare (UA)
Number of subjects: 200
Study: 35760542

Group type: EXPERIMENTAL
Intervention: Microbiota mixture (two enemas of deep-frozen stored stool microbiota mixed from eight healthy donors)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo (two enemas of autoclaved microbiota mixture)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo (only)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Microbiota mixture
Number of subjects: 99
Study: 35152197

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy with induction chemotherapy (Cisplatin 75 mg/m2 and Paclitaxel 175 mg/m2 every 21 days) followed by concurrent chemoradiotherapy (66Gy in 33 fractions for 6.5 weeks)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (Cisplatin 40 mg/m2 intravenous during chest radiotherapy of 66Gy in 33 fractions for 6.5 weeks)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy followed by concurrent chemoradiotherapy
Number of subjects: 25

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy alone
Number of subjects: 25
Study: 32598472

Group type: EXPERIMENTAL
Intervention: Coban spiral application to fingers, figure of eight to hand and wrist
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Coban pinch application to fingers, spiral application to hand and wrist
Number of subjects: 100

Group type: COMPARATOR
Intervention: Generic compression glove
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: All compression methods
Number of subjects: 100
Study: 35788632

Group type: EXPERIMENTAL
Intervention: Multispecies probiotic (specific strains corrected in the erratum)
Number of subjects: 0
Study: 32881641

Group type: EXPERIMENTAL
Intervention: Convalescent plasma therapy, with anti-SARS-CoV-2 titers of >1:640 to >1:1000, dosage and duration not specified.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Convalescent plasma therapy, details on dosage and duration not specified.
Number of subjects: 0
Study: 35576407

Group type: EXPERIMENTAL
Intervention: SafeCare augmented for an urban high‐risk population (SC+)
Number of subjects: 562

Group type: COMPARATOR
Intervention: Standard home‐based mental health services (SAU)
Number of subjects: 562
Study: 36326400

Group type: EXPERIMENTAL
Intervention: High-frequency (10Hz) TMS
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Treatment response
Number of subjects: 38
Study: 36180870

Group type: EXPERIMENTAL
Intervention: Wobble Board Training with Cognitive Intervention (n=7)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Wobble Board Training without Cognitive Intervention (n=7)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (n=7)
Number of subjects: 21
Study: 34018965

Group type: EXPERIMENTAL
Intervention: Clinician hydroxyurea SDM toolkit (H-SDM toolkit)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Clinician pocket guide (usual care)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 120
Study: 32915939

Group type: EXPERIMENTAL
Intervention: Tretinoin lotion 0.05%
Number of subjects: 0
Study: 35638317

Group type: EXPERIMENTAL
Intervention: Duloxetine (60 mg daily for 18 weeks)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 32687757

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo or standard treatment not specified)
Number of subjects: 0
Study: 35100456

Group type: EXPERIMENTAL
Intervention: WaveOne Gold (WO) used in reciprocation
Number of subjects: 66

Group type: COMPARATOR
Intervention: One Shape (OS) used in continuous rotation
Number of subjects: 66
Study: 35093946

Group type: EXPERIMENTAL
Intervention: 10 mg of Rosuvastatin in addition to SSRIs therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo in addition to SSRIs therapy
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 10 mg of Rosuvastatin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 34367303

Group type: EXPERIMENTAL
Intervention: Auricular Point Acupressure (APA)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Compound Lidocaine Cream (CLC)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: APA combined with CLC
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 35833071

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 60
Study: 36079732

Group type: EXPERIMENTAL
Intervention: Supplement containing Sambucus nigra, zinc, tyndallized Lactobacillus acidophilus (HA122), arabinogalactans, vitamin D, vitamin E, and vitamin C for 30 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (young patients)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (elderly patients)
Number of subjects: 0
Study: 33340680

Group type: EXPERIMENTAL
Intervention: Chlorhexidine alcohol with 3% hydrogen peroxide (HP)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Chlorhexidine alcohol (control group)
Number of subjects: 151
Study: 37179984

Group type: EXPERIMENTAL
Intervention: Cervical total disc arthroplasty (CTDA)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Cervical lordosis (CL)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Cervical sagittal vertical alignment (cSVA)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: T1 slope
Number of subjects: 98
Study: 33360382

Group type: EXPERIMENTAL
Intervention: Postural Wobble Board (P-WB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ballistic force
Number of subjects: 0

Group type: COMPARATOR
Intervention: Accuracy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rest (Control group)
Number of subjects: 0
Study: 33118956

Group type: EXPERIMENTAL
Intervention: Adapted cognitive-behavioral stress management (CBSM) course and physical activity promotion via WeChat
Number of subjects: 150
Study: 33713211

Group type: EXPERIMENTAL
Intervention: Paclitaxel-Coated Balloon (DCB)
Number of subjects: 170

Group type: COMPARATOR
Intervention: New-Generation Drug-Eluting Stents (DES)
Number of subjects: 170
Study: 34478616

Group type: EXPERIMENTAL
Intervention: IAP 2015 BMI chart
Number of subjects: 1418

Group type: EXPERIMENTAL
Intervention: WHO 2007 BMI chart
Number of subjects: 1418
Study: 32201141

Group type: EXPERIMENTAL
Intervention: Simulator-enhanced training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All students performing biopsies in a real-life situation
Number of subjects: 24
Study: 35025157

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 90
Study: 35792037

Group type: EXPERIMENTAL
Intervention: Remotely delivered exercise program for 3 months
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study: 35897500

Group type: EXPERIMENTAL
Intervention: BUD application (app) for food distribution
Number of subjects: 38

Group type: COMPARATOR
Intervention: Comparison group (not specified)
Number of subjects: 38
Study: 33761570

Group type: EXPERIMENTAL
Intervention: Individualized homeopathic medicines (IH)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 36229199

Group type: EXPERIMENTAL
Intervention: Severe PMNE group
Number of subjects: 43
Study: 33065342

Group type: EXPERIMENTAL
Intervention: Ribociclib plus fulvestrant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus fulvestrant
Number of subjects: 0
Study: 33438346

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) with microneedling
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) without microneedling
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (medical treatment only)
Number of subjects: 126
Study: 32925621

Group type: EXPERIMENTAL
Intervention: Combination therapy (mifepristone and misoprostol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monotherapy (misoprostol alone)
Number of subjects: 0
Study: 34304203

Group type: EXPERIMENTAL
Intervention: Early laser (group 1) at 1 week after IVR
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Deferred laser (group 2) at 6 weeks or earlier after IVR
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Early laser (group 1)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Deferred laser (group 2)
Number of subjects: 32
Study: 34922723

Group type: EXPERIMENTAL
Intervention: Full-occlusion biofeedback splint
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 32073619

Group type: EXPERIMENTAL
Intervention: Iron from ASP‐p (Aspergillus oryzae grown in FePP)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Iron from FePP (ferric pyrophosphate)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Iron from FeSO4 (ferrous sulfate)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: ASP‐p iron absorption
Number of subjects: 35
Study: 32089025

Group type: EXPERIMENTAL
Intervention: Counseling based on Gamble’s approach (3 sessions before delivery and 1 postpartum)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine prenatal care (control group)
Number of subjects: 60
Study: 34135049

Group type: EXPERIMENTAL
Intervention: Calcium electroporation
Number of subjects: 30
Study: 33613521

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) as adjunct therapy during the first two months of anti-TB treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35560474

Group type: EXPERIMENTAL
Intervention: Acute heat exposure (passive heat stress using a water-perfused suit to increase body core temperature by 1.2 °C)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Voluntary hypoxic apneas (performed in duplicate before acute heat exposure and in recovery)
Number of subjects: 6
Study: 33890858

Group type: EXPERIMENTAL
Intervention: Big White Wall (BWW)
Number of subjects: 790

Group type: COMPARATOR
Intervention: Moodzone (MZ)
Number of subjects: 790
Study: 34895479

Group type: EXPERIMENTAL
Intervention: COPP (n=444)
Number of subjects: 1287

Group type: EXPERIMENTAL
Intervention: COPDAC (n=448)
Number of subjects: 1287

Group type: COMPARATOR
Intervention: COPDAC
Number of subjects: 1287

Group type: EXPERIMENTAL
Intervention: OEPA
Number of subjects: 1287

Group type: EXPERIMENTAL
Intervention: COPP
Number of subjects: 1287
Study: 34380637

Group type: EXPERIMENTAL
Intervention: Neratinib + Capecitabine (N+C)
Number of subjects: 621
Study: 32919064

Group type: EXPERIMENTAL
Intervention: Parental concussion symptom knowledge measured using 25 questions (score range 0-50)
Number of subjects: 1224

Group type: EXPERIMENTAL
Intervention: Parental care-seeking attitudes measured using five 7-point scale items (score range 5-35)
Number of subjects: 1224

Group type: EXPERIMENTAL
Intervention: Higher parental age (10-year increase)
Number of subjects: 1224

Group type: EXPERIMENTAL
Intervention: Higher competitiveness (10%-scale increase)
Number of subjects: 1224

Group type: EXPERIMENTAL
Intervention: White/non-Hispanics vs. other racial or ethnic groups
Number of subjects: 1224
Study: 35329107

Group type: EXPERIMENTAL
Intervention: Synbiotic (Gasteel Plus®) administered for 30 days
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo administered for 30 days
Number of subjects: 27
Study: 32107700

Group type: EXPERIMENTAL
Intervention: Community-based organized football program
Number of subjects: 40

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 40
Study: 34459959

Group type: EXPERIMENTAL
Intervention: 2000 IU/day vitamin D for 6 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 33038950

Group type: EXPERIMENTAL
Intervention: Immediate intravenous bolus of 10% dextrose at 5 mL/kg followed by a 24-h maintenance infusion of 10% dextrose at 100 mL/kg for the first 10 kg of bodyweight, 50 mL/kg for the next 10 kg, and 20 mL/kg for each subsequent kg of bodyweight.
Number of subjects: 322

Group type: COMPARATOR
Intervention: Observation for a minimum of 60 min and standard care.
Number of subjects: 322
Study: 35440459

Group type: EXPERIMENTAL
Intervention: ACT-based guided self-help intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study: 34519670

Group type: EXPERIMENTAL
Intervention: MyT1DHero app intervention
Number of subjects: 30
Study: 34044151

Group type: EXPERIMENTAL
Intervention: CDCM (mouthwash with β‐cyclodextrin and citrox)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 36155131

Group type: EXPERIMENTAL
Intervention: Plasma exchange
Number of subjects: 704

Group type: COMPARATOR
Intervention: No plasma exchange
Number of subjects: 704

Group type: EXPERIMENTAL
Intervention: Reduced-dose glucocorticoid regimen
Number of subjects: 704

Group type: COMPARATOR
Intervention: Standard-dose glucocorticoid regimen
Number of subjects: 704
Study: 33865473

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 34415992

Group type: EXPERIMENTAL
Intervention: 8-week low-calorie diet (LCD) at 800 kcal/day
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Throughout all phases of the DI
Number of subjects: 556
Study: 34160401

Group type: EXPERIMENTAL
Intervention: Self-administered acupressure
Number of subjects: 154

Group type: COMPARATOR
Intervention: Sham acupoint
Number of subjects: 154
Study: 34357513

Group type: EXPERIMENTAL
Intervention: Anti-Ebola web server with machine learning models
Number of subjects: 305
Study: 32062173

Group type: EXPERIMENTAL
Intervention: High-dose TxA (30 mg/kg bolus, 16 mg/kg/h maintenance, 2 mg/kg pump prime)
Number of subjects: 3008

Group type: COMPARATOR
Intervention: Low-dose TxA (10 mg/kg bolus, 2 mg/kg/h maintenance, 1 mg/kg pump prime)
Number of subjects: 3008

Group type: EXPERIMENTAL
Intervention: High-dose TxA
Number of subjects: 3008

Group type: COMPARATOR
Intervention: Low-dose TxA
Number of subjects: 3008
Study: 34320899

Group type: EXPERIMENTAL
Intervention: Accelerated Skill Acquisition Program (ASAP) for 2 hours
Number of subjects: 18

Group type: COMPARATOR
Intervention: Usual and customary care (Control)
Number of subjects: 18
Study: 33332190

Group type: EXPERIMENTAL
Intervention: Gefitinib
Number of subjects: 222

Group type: COMPARATOR
Intervention: Vinorelbine plus Cisplatin (VP)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Subsequent therapy (both groups)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Subsequent targeted therapy
Number of subjects: 222